Varex Imaging (NASDAQ:VREX) updated its FY19 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $1.30-1.45 for the period, compared to the Thomson Reuters consensus estimate of $1.28. The company issued revenue guidance of $790-805 million, compared to the consensus revenue estimate of $782.32 million.
A number of research firms have issued reports on VREX. BidaskClub upgraded shares of Varex Imaging from a hold rating to a buy rating in a research report on Thursday, October 31st. JPMorgan Chase & Co. cut their target price on shares of Varex Imaging from $34.00 to $32.00 and set a neutral rating on the stock in a research note on Wednesday. ValuEngine lowered shares of Varex Imaging from a hold rating to a sell rating in a research note on Thursday, October 10th. Oppenheimer initiated coverage on shares of Varex Imaging in a research note on Tuesday, October 22nd. They issued an outperform rating and a $40.00 price target on the stock. Finally, Jefferies Financial Group set a $31.00 price target on shares of Varex Imaging and gave the company a buy rating in a research note on Monday, August 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the stock. The stock presently has an average rating of Buy and an average target price of $35.83.
Shares of NASDAQ:VREX opened at $29.78 on Friday. Varex Imaging has a 12-month low of $21.57 and a 12-month high of $35.00. The company has a current ratio of 2.58, a quick ratio of 1.04 and a debt-to-equity ratio of 0.87. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 22.91, a PEG ratio of 3.02 and a beta of 1.90. The stock’s 50-day moving average price is $29.44 and its two-hundred day moving average price is $29.19.
In other news, CFO Clarence R. Verhoef sold 21,047 shares of the business’s stock in a transaction on Wednesday, October 16th. The stock was sold at an average price of $28.94, for a total transaction of $609,100.18. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Mark S. Jonaitis sold 13,530 shares of the business’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $31.02, for a total value of $419,700.60. The disclosure for this sale can be found here. Corporate insiders own 2.40% of the company’s stock.
Varex Imaging Company Profile
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers, and buckys.
Recommended Story: Call Option
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.